CPS Logo

All Publications

2021

figure from publication

Biorelevant and screening dissolution methods for minocycline hydrochloride microspheres intended for periodontal administration

Patel SK, Greene AC, Desai SM, Rothstein S, Basha IT, MacPherson JS, Wang Y, Zou Y, Shehabeldin M, Sfeir CS, Little SR, Rohan LC

Int J Pharm. 2021 Mar 1:596:120261. DOI: 10.1016/j.ijpharm.2021.120261 PMID: 33486044

Read More... from Biorelevant and screening dissolution methods for minocycline hydrochloride microspheres intended for periodontal administration

2020

Figure from article

Maternal immunization with adjuvanted RSV prefusion F protein effectively protects offspring from RSV challenge and alters innate and T cell immunity

Eichinger KM, Kosanovich JL, Lipp MA, Perkins TN, Petrovsky NP, Marshall CP, Yondola MA, Empey KM.

Vaccine. 2020 Nov 25;38(50):7885-7891. DOI: 10.1016/j.vaccine.2020.10.065. PMID: 33129608.

Read More... from Maternal immunization with adjuvanted RSV prefusion F protein effectively protects offspring from RSV challenge and alters innate and T cell immunity

Figure from article

Impact of the CYP2C19*17 allele on outcomes in patients receiving CYP2C19 genotype-guided antiplatelet therapy after percutaneous coronary intervention

Lee CR, Thomas CD, Beitelshees AL, Tuteja S, Empey PE, Lee JC, Limdi NA, Duarte JD, Skaar TC, Chen Y, Cook KJ, Coons JC, Dillon C, Franchi F, Giri J, Gong Y, Kreutz RP, McDonough CW, Stevenson JM, Weck KE, Angiolillo DJ, Johnson JA, Stouffer GA, Cavallari LH.

Clin Pharmacol Ther. 2021 Mar;109(3):705-715. DOI: 10.1002/cpt.2039. PMID: 32897581.

Read More... from Impact of the CYP2C19*17 allele on outcomes in patients receiving CYP2C19 genotype-guided antiplatelet therapy after percutaneous coronary intervention

Article Cover

Formulation of the prefusion RSV F protein with a Th1/Th2-balanced adjuvant provides complete protection without Th2-skewed immunity in RSV-experienced young mice

Kosanovich JK, Eichinger KM, Lipp MA, Yondola MA, Perkins TN, Empey KM.

Vaccine. 2020 Sep 22;38(41):6357-6362. DOI: 10.1016/j.vaccine.2020.08.023. PMID: 32829976.

Read More... from Formulation of the prefusion RSV F protein with a Th1/Th2-balanced adjuvant provides complete protection without Th2-skewed immunity in RSV-experienced young mice

Figure from article

Prefusion RSV F immunization elicits Th2-mediated lung pathology in mice when formulated with a Th2) but not a Th1/Th2-balanced) adjuvant despite complete viral protection

Eichinger KM, Kosanovich JL, Gidwani SV, Zomback A, Lipp MA, Perkins TN, Oury TD, Petrovsky N, Marshall CP, Yondola MA, Empey KM.

Front Immunol. 2020 Jul 29:11:1673. DOI: 10.3389/fimmu.2020.01673. PMID: 32849580.

Read More... from Prefusion RSV F immunization elicits Th2-mediated lung pathology in mice when formulated with a Th2) but not a Th1/Th2-balanced) adjuvant despite complete viral protection